A clear guide to GLP-1 receptor agonists, the class of medications behind Ozempic, Wegovy, and more. Learn what they are, how they work in the body, and how the different options compare for diabetes and weight loss.
GLP-1 Agonists
One of the most common fears among people on GLP-1 medications is what happens when they stop. New research points to a promising gut-based strategy that may help hold off rebound weight gain — and it's simpler than you might expect.
A Medicare pilot program designed to bring GLP-1 medications to older adults at a steep discount is losing steam — because insurers won't participate. Understanding why they're walking away matters if you're a senior counting on coverage for semaglutide or tirzepatide.
A growing number of people on GLP-1 medications are reporting more than just weight loss — they're noticing changes in their mood, motivation, and emotional range. Is "Ozempic personality" a real side effect, or something else entirely? Here's what the evidence actually shows.
Injectable GLP-1 medications changed obesity treatment. Now oral versions from two pharmaceutical giants are entering the market. If you're on GLP-1 therapy—or thinking about starting—here's what the pill option actually means for you.
People on semaglutide are reporting more than just weight loss — some notice shifts in mood, motivation, and even how they relate to food emotionally. Dubbed "Ozempic personality," this phenomenon is getting serious attention from clinicians. Here's what's actually happening in your brain.
Complete 2026 guide to GLP-1 weight loss medications.
Complete guide to tirzepatide, Mounjaro, and Zepbound in 2026.
How Wegovy works for weight loss and how to get started.
.avif)
.avif)